… accumulation and chronic inflammatory factor levels on RFS in patients with lung cancer,
we analyzed their interrelationships using Kaplan-Meier survival curves. Two …

… MDSC have been identified in the peripheral blood of NSCLC and small cell lung cancer
patients … to the predominant type of MDSC in cancer patients, with some studies showing that M-…

… The aim of this systematic review is to select studies for a meta-analysis, which compares
prognosis between patients with high vs low circulating MDSC levels. We collected hazard …

… According to the findings of this small-scale pilot study, circulating M-MDSCs, but not G-MDSC,
are elevated in NSCLC patients compared to healthy volunteers. There was a trend …

… They showed that the lncRNA RUNXOR exhibited upregulated expression in MDSCs isolated
from the peripheral blood of LC patients and that the expression of RUNX1, a target gene …

… of MDSCs and their association with the clinical outcome were investigated in non-small
cell lung cancer (NSCLC) patients. The percentages and correlation between MDSCs and …

… to immunotherapy for several cancers. Here, we describe … MDSCs (M-MDSC) overexpressing
TIE2, the receptor for angiopoietin-2 (ANGPT2), in patients with non–small cell lung cancer …

… or MDSCs in lung cancer remain to be elucidated. In the present study, 36 patients newly
diagnosed with lung cancer based on the guidelines of the International Union Against Cancer …

… interaction of tumors with MDSCs that lead to dysregulation of … in lung cancer modulate
the activities of MDSCs and impact … In cancer patients, MDSCs are identified by surface …

… A high number of MDSCs have been observed in patients with NSCLC, breast cancer,
and head and neck cancer (13). Increased levels of circulating MDSCs have recently been …